Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer ; volume:15 ; number:1 ; day:1 ; month:5 ; year:2015 ; pages:1-10 ; date:12.2015
BMC cancer ; 15, Heft 1 (1.5.2015), 1-10, 12.2015
- Creator
-
Bondarenko, Igor M.
- Contributor
-
Ingrosso, Antonella
Bycott, Paul
Kim, Sinil
Cebotaru, Cristina L.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1350-6
- URN
-
urn:nbn:de:1111-2016110618720
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bondarenko, Igor M.
- Ingrosso, Antonella
- Bycott, Paul
- Kim, Sinil
- Cebotaru, Cristina L.
- SpringerLink (Online service)
Other Objects (12)
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy
The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer
Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC
Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC
Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study
A scotogenic model with two inert doublets
Effective field theory with two Higgs doublets
Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy
The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer
Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC
Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC
Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study
A scotogenic model with two inert doublets
Effective field theory with two Higgs doublets
Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy
The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer
Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC
Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC
Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study
A scotogenic model with two inert doublets
Effective field theory with two Higgs doublets